PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

top 9 Side Effects of Zepbound (Doctors Never Say This) | Zepbound Side Effects

16:32Dec 2025

Today’s cheapest Zepbound$348/mo at Lemonaid Health, medication and membership billed separately.Compare all Zepbound prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. Not from the video’s creator.

Our summary

According to the video, Zepbound is a weekly injection that clinical trials link to up to 52 lbs of weight loss over 72 weeks. The narrator says the medication insert lists many adverse reactions that doctors may not have time to explain in a short visit, so the video goes through nine side effects in turn. It draws mostly on FDA prescribing information and the SURMOUNT trials.

Published by Health Talk on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

The video starts with gastrointestinal problems. It says nausea affects about 29 to 33% of users, diarrhea 19 to 21%, and vomiting 9 to 13%, and that these were the leading reason people stopped treatment in trials, with up to 4.3% stopping at the 10 and 15 mg doses. It then covers injection site reactions, which it says were reported by 11.3% of patients with antibodies against tirzepatide versus 1% of those without. Next is hypoglycemia, which it describes as a greater concern when Zepbound is combined with insulin or sulfonylureas. It reports 4.2% of treated patients with type 2 diabetes had glucose below 54 mg per deciliter, compared with 1.3% on placebo.

The narrator also describes the boxed warning on thyroid C-cell tumors seen in rats, pancreatitis, gallbladder problems, heart rate increases of 2.1 to 5.4 beats per minute depending on dose, acute kidney injury linked to dehydration, and severe allergic reactions including anaphylaxis. For each, the video lists symptoms to watch for. It closes by saying many effects can be managed with dose changes and medical supervision, and that the decision to use Zepbound should be made with a healthcare provider.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 1:32 The video says nausea, diarrhea and vomiting are the most common side effects and the leading reason people stopped treatment in trials.
  2. 3:04 It says injection site reactions were reported more often by patients who developed antibodies against tirzepatide (11.3% versus 1%).
  3. 4:36 The narrator says hypoglycemia risk rises when Zepbound is combined with insulin or sulfonylureas.
  4. 5:40 According to the video, the label carries a boxed warning for thyroid C-cell tumors based on rodent studies, and Zepbound is contraindicated with a personal or family history of medullary thyroid carcinoma.
  5. 7:42 The video describes pancreatitis and gallbladder problems, including persistent severe abdominal pain as a warning sign.
  6. 11:16 It covers heart rate and blood pressure changes, kidney injury linked to dehydration, and severe allergic reactions, advising prompt medical attention for serious symptoms.

Key moments

Tap one to play from there.

  1. 0:34 Side effects
  2. 3:08 Injection technique
  3. 4:47 How it works
  4. 7:34 The trials
  5. 10:29 Dose change
  6. 12:48 Side effects

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound
Side effects mentioned
nausea, vomiting, diarrhea, dizziness, dehydration, gallbladder and pancreatitis

Questions this video answers

What are the most common side effects of Zepbound?

According to the video, gastrointestinal effects are the most common. It cites nausea in about 29 to 33% of users, diarrhea in 19 to 21%, and vomiting in 9 to 13%. It says these were the leading reason for stopping treatment in trials.

Does Zepbound have a boxed warning?

The video says yes, for thyroid C-cell tumors. It explains this comes from animal studies in rats, and that the label says it is unknown whether Zepbound causes these tumors in humans. It says Zepbound is contraindicated with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Can Zepbound cause low blood sugar?

The video says it can, particularly when taken with insulin or sulfonylureas. It reports 4.2% of treated patients with type 2 diabetes had glucose below 54 mg per deciliter, versus 1.3% on placebo, and says the label recommends reducing insulin or sulfonylurea doses when starting Zepbound.

Can Zepbound affect the kidneys?

According to the video, acute kidney injury has been reported, mostly in patients who became dehydrated from nausea, vomiting or diarrhea. It cites 0.5% of Zepbound patients versus 0.2% on placebo, and says staying hydrated is critical.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Zepbound side effects: the label's table by dose, who actually quits, and how it compares to semaglutide

    Zepbound's label puts a number on every common side effect at each of its three maintenance doses. Nausea runs 25 to 29 percent against 8 on placebo, diarrhoea 19 to 23, vomiting 8 to 13, constipation 11 to 17. Across the two approval trials, 4.8 to 6.7 percent of people stopped the drug because of side effects, against 3.4 percent on placebo, and most of those who quit did so in the first months, from gut effects during dose escalation. Below that table are the rarer things the label warns about, with the trial rates where it gives them, and the honest comparison to Ozempic's table.

  • What is Zepbound? Tirzepatide explained: what it treats, how it works, and what it costs

    Zepbound is Eli Lilly's brand of tirzepatide, a once-weekly injection that acts on two hormone receptors, GIP and GLP-1. The FDA label approves it, with diet and exercise, for weight reduction in adults with obesity or overweight plus a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. In the SURMOUNT-5 trial it produced 20.2% average weight loss at 72 weeks against 13.7% for semaglutide. Lilly sells it self-pay from $299 a month.

  • Zepbound dosage chart: every tirzepatide dose, the escalation rule, what each rung lost in the trial, and what it costs

    Zepbound has six doses, 2.5 to 15 mg, taken once a week. The label's rule is four weeks at 2.5 mg, then 2.5 mg steps with at least four weeks on each, to a maintenance dose of 5, 10 or 15 mg. In SURMOUNT-1 those three doses lost 15.0, 19.5 and 20.9 percent of body weight over 72 weeks. Direct from Lilly each rung has a price, $299 at 2.5 mg rising to $699 at 10 mg and above, so the chart below carries the dose, the rule, the trial result and the bill in one place, plus the vial and KwikPen concentrations for anyone measuring in units.

Next steps

Zepbound prices

Insurance

Find more like it

Side effectsDose changeWeigh-in and resultsInjection techniqueHow it worksThe trialsNauseaVomitingDiarrheaDizziness

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV